Skip to main content

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment

Last Updated: March 30, 2022
Status: Current

Products Affected - Description
    • Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Perrigo, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 00574-4160-35
Reason for the Shortage
    • Bausch Health has neomycin/polymyxin B sulfates/dexamethasone ophthalmic ointment available.
    • Novartis has Maxitrol ointment available.
    • Perrigo did not provide a reason for the shortage.
    • Sandoz has neomycin/polymyxin B sulfates/dexamethasone ophthalmic ointment available.
Available Products
    • Maxitrol ophthalmic ointment, Novartis, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 00078-0771-01
    • Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Bausch Health, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 24208-0795-35
    • Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Sandoz, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 61314-0631-36

Estimated Resupply Dates

    • Perrigo has temporarily discontinued neomycin/polymyxin B/dexamethasone ophthalmic ointment in 3.5 gram tubes and the company cannot estimate a release date. All other presentations are available.

Updated

Updated March 30, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 17, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.